Consistently, the overexpression of SENP1 or HIF-1α significantly restored the CLDN6-mediated reductions in circulating tumour cells, indicating that CLDN6 inhibits breast cancer metastasis through SENP1/HIF-1α signalling in vivo. Here, CLDN6 is linked to breast carcinoma.